Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immunic, Inc. - Common Stock
(NQ:
IMUX
)
15.93
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunic, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
August 21, 2023
--News Direct--
Via
News Direct
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
August 21, 2023
Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced the completion of the enrolment of its phase 2 CALLIPER trial...
Via
TheNewswire.com
Immunic CEO says Q2 results "couldn't be better"
August 07, 2023
--News Direct--
Via
News Direct
Immunic CEO says Q2 results "couldn't be better"
August 07, 2023
Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive following the release of the Munich-based biotechnology company's second-quarter financial results and...
Via
TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
July 25, 2023
Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt joined Thomas Warner from Proactive ahead of World Brain Day to provide an update on the biotechnology company's novel multiple sclerosis (MS)...
Via
TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
July 25, 2023
--News Direct--
Via
News Direct
Immunic Inc set to bring relief with encouraging results
May 16, 2023
Immunic Inc set to bring relief with encouraging results
Via
News Direct
Immunic Inc set to bring relief with encouraging results
May 16, 2023
Dr Daniel Vitt, CEO of Immunic Inc (NASDAQ:IMUX), discusses the company's encouraging first-quarter performance with Proactive.
Via
TheNewswire.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 28, 2023
Via
Benzinga
Recap: Immunic Q1 Earnings
↗
May 11, 2023
Via
Benzinga
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
May 04, 2023
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Via
News Direct
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
May 04, 2023
Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Thomas Warner from Proactive after releasing new clinical trial data for the biotechnology company's IMU-856 molecule, which is aimed at...
Via
TheNewswire.com
Immunic gets a "positive surprise" from lead asset trial
April 13, 2023
Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838)...
Via
TheNewswire.com
Why Is Immunic (IMUX) Stock Up 23% Today?
↗
April 05, 2023
Immunic (IMUX) stock is getting a boost on Wednesday after the company released results from its Phase 2 CALDOSE-1 Trial.
Via
InvestorPlace
Preview: Immunic's Earnings
↗
February 22, 2023
Via
Benzinga
Immunic Touts Positive Vidofludimus Calcium Data In Multiple Sclerosis Candidate
↗
November 17, 2022
Via
Benzinga
Immunic gets a "positive surprise" from lead asset trial
April 13, 2023
Immunic gets a "positive surprise" from lead asset trial
Via
News Direct
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
April 05, 2023
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite...
Via
Benzinga
After Positive Data In Ulcerative Colitis Study, Immunic Prioritizes Vidofludimus Calcium Program With One More Candidate
↗
April 05, 2023
Via
Benzinga
Why Is Nuvve (NVVE) Stock Down 14% Today?
↗
April 05, 2023
Nuvve (NVVE) stock is down on Wednesday after the vehicle-to-grid technology company's shares underwent a rally yesterday.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
April 05, 2023
Via
Benzinga
Why Is Secoo (SECO) Stock Down 16% Today?
↗
April 05, 2023
Secoo (SECO) stock is retreating on Wednesday after the Chinese products and services company saw a massive rally on Tuesday.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
April 05, 2023
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
December 15, 2022
Via
Benzinga
BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
↗
November 28, 2022
The Dow Jones closed higher by more than 150 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 17, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
November 17, 2022
We're beginning the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday morning!
Via
InvestorPlace
Recap: Immunic Q3 Earnings
↗
November 03, 2022
Immunic (NASDAQ:IMUX) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Immunic missed estimated earnings...
Via
Benzinga
Immunic's Earnings Outlook
↗
November 02, 2022
Immunic (NASDAQ:IMUX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Immunic will report...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
